SBI Life Insurance: Should you buy, sell or hold after Q4 results?

Synopsis: Insurance stock gains traction after strong 19 percent premium growth and improving margins, with brokerages remaining positive on growth visibility and stable fundamentals, suggesting upside potential of around 30 percent.

The share of this company, which offers comprehensive protection, savings, and pension plans via a massive bancassurance network, gained investor traction after the company announced Q4 results and brokerage being bullish on the stock

With a market capitalization of Rs 1,83,565 crore, SBI Life Insurance Company Ltd’s shares on Thursday made a day high of Rs 1886.10 per share, 0.17 percent from its previous day’s close price of Rs 1,886.10 per share. The share of this company has given a 98 percent return over the last five years.

Results Highlight

• QoQ View: Net premium income declined about 8.5 percent QoQ to Rs 27,683.79 crore in Q4 FY26 from Rs 30,245.32 crore in Q3 FY26. First-year premium stood at Rs 5,092.71 crore, renewal premium at Rs 16,743.96 crore, and single premium at Rs 6,132.18 crore. PAT rose about 39.5 percent QoQ to Rs 804.64 crore from Rs 576.74 crore.
• YoY View: Net premium income rose about 16.1 percent YoY to Rs 27,683.79 crore in Q4 FY26 from Rs 23,860.71 crore in Q4 FY25. PBT declined about 3.0 percent to Rs 815.78 crore from Rs 840.61 crore, while PAT fell about 1.1 percent to Rs 804.64 crore from Rs 813.51 crore, reflecting mild profitability pressure.
• Fiscal Year comparison: Net premium income rose about 18.9 percent to Rs 99,959.92 crore in FY26 from Rs 84,059.83 crore in FY25. PBT increased about 1.7 percent to Rs 2,537.40 crore from Rs 2,494.67 crore, while PAT grew about 2.4 percent to Rs 2,470.30 crore from Rs 2,413.30 crore, reflecting steady annual performance.

Business Performance

Strong Market Leadership and Business Scale: The company maintained strong private market leadership in individual new business premiums with 25.5 percent share and a rated premium share of 22.9 percent. APE grew 13 percent to Rs 242.7 billion, while new business sum assured surged 61 percent to Rs 4,463 billion, reflecting strong business momentum.

Improving Persistency and Value Creation: Value of new business rose 12 percent to Rs 66.7 billion with a healthy margin of 27.5 percent. Persistency improved by 53 bps in 13M and 107 bps in 49M cohorts, indicating better customer retention and strengthening long-term earnings visibility across policies.

Strong Embedded Value and Financial Stability: Indian embedded value grew 15 percent to Rs 807.9 billion, supported by an operating ROEV of 19.7 percent. PAT rose 2 percent to Rs 24.7 billion, while assets under management increased 9 percent to Rs 4.9 trillion, with a strong solvency ratio of 1.90 indicating financial stability.

Brokerage Views

Morgan Stanley maintained an Overweight rating on SBI Life Insurance but cut target price to Rs 2,340 from Rs 2,375, reflecting a slightly softer near-term outlook while still retaining a positive long-term stance.

Operating Profit Beat in FY26: The operating profit for FY26 came in about 6 percent higher than estimates, mainly due to better-than-expected operating performance. This shows that the core business worked more efficiently than expected, helping improve overall value creation during the year.

Overall Value and Margin Miss:  The overall embedded value for FY26 was almost in line with expectations, slightly higher by 0.2 percent. However, the value of new business was 5 percent lower than expected because of weaker group protection sales and lower margins, which reduced overall profitability from new policies.

Outlook and Profitability Strength: For FY27, the company expects premium growth of 14 percent and value of new business margins in the range of 27 to 28 percent. Strong return on embedded value, better customer retention, and improved commission structure support a positive outlook, making the future risk and reward balance more favourable.

SBI Life Insurance Company maintains an Outperform rating with a target price of Rs 2,360 from Macquarie, implying around 30 percent upside from its current low, supported by steady performance, stable margins, and resilient growth outlook.

Stable Performance and Positive Outlook: The company maintains an Outperform rating with a target price of Rs 2,360, supported by steady operational performance and strong underlying fundamentals. The business continues to show consistency, with no major deterioration in core metrics, indicating resilience in its long-term growth trajectory.

Growth and Margin Stability: Value of new business came in line with expectations, while annual premium equivalent growth remains moderate but still stronger than several large peers. The impact on value of new business margin was limited due to a favourable product mix, and the annual premium equivalent growth guidance remains unchanged, supporting steady forward visibility.

About the Company

SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a joint venture between the State Bank of India and BNP Paribas Cardif S.A. It offers comprehensive protection, savings, and pension plans via a massive bancassurance network. As of 2026, it boasts a ~98-99 percent claim settlement ratio and high growth in new business premiums.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post SBI Life Insurance: Should you buy, sell or hold after Q4 results? appeared first on Trade Brains.